The Italian Olympic Committee's anti-doping prosecutor has indicated he
may open an investigation into a genetic therapy being used to treat the
injured thigh of AC Milan forward Ronaldo.
"I'm waiting for news, and it's not been said that we won't open an
inquiry," prosecutor Ettore Torri told the ANSA news agency Monday.
Ronaldo is being treated in Brazil under the supervision of national
team physician Jose Luis Runco. The therapy, called growth factor, uses
a natural protein to stimulate cell proliferation. The practice is
banned in Italy.
"I'm waiting for some answers from the Italian soccer federation and I
will also ask the Olympic committee's physicians for an opinion," Torri
Ronaldo was hurt July 31 during Milan's preseason training and hasn't
Milan's physicians originally diagnosed Ronaldo's injury as a muscle
strain and said he could return against Siena on Saturday. Further tests
revealed a more serious tear that could keep him out another month.
"We made a mistake in our first evaluation," Milan medical coordinator
Jean Pierre Meersseman was quoted as saying on the club's Web site
Monday. "I'm in contact with Runco, who has explained to me what he
intends to do."